The National Institute of Health and Care Excellence (NICE) has published new guidance for the month of August 2013. This month there are two clinical guidelines and one technology appraisal that impact upon primary care.
The Acute kidney injury guideline provides evidence-based advice on the prevention, detection and management of acute kidney injury. It recommends assessment for kidney injury in acutely ill individuals with risk factors such ask chronic kidney disease, heart failure, diabetes and those using nephrotoxic drugs.
The Autism - management of autism in children and young people guideline provides evidence-based advice on the care and management of children and young people with autism. Effective communication is encouraged and should include families and carers. The guideline includes recommendations on anticipating and preventing behaviour that challenges as well as treatment interventions.
The Breast cancer - everolimus technology appraisal does not recommend the use of this drug in combination with exemestane for treating advanced HER2-negative hormone-receptor-positive breast cancer after endocrine therapy. The review concluded that it does not provide enough benefit to patients to justify its high cost.
Action: Clinicians should be aware of this month's new guidance and implement any necessary changes to practice.
|« MTRAC Reviews - August 2013||SMC Update - September 2013 »|